Related Experiment Video
Updated: Aug 7, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 31, 2013
Mad1 suppresses bladder cancer cell proliferation by inhibiting human telomerase reverse transcriptase transcription
Lin Zou1, Penghui Zhang, Chunli Luo
1Faculty of Laboratory Medicine at Chongqing University of Medical Sciences, Key Laboratory of Laboratory Medical Diagnosis of Education Ministry, Chongqing, China.
Objectives:
To study the effects and possible mechanisms of mitosis arrest deficiency 1 (Mad1), the heterodimerizer of Max and a transcriptional repressor, on cell proliferation of bladder cancer in vitro and in vivo.
Methods:
Combining methyl thiazolyl tetrazolium (MTT) assay, flow cytometry, luciferase assay, telomeric repeat amplification protocol-enzyme-linked immunosorbent assay, real-time reverse transcriptase polymerase chain reaction, experimental animal models, and other assays, we detected the alterations of cell proliferation, cell cycle, promoter activity and expression of human telomerase reverse transcriptase (hTERT), and telomerase activity in different treated bladder cells and xenograft tissues.
Results:
Mad1 inhibited cell proliferation, increased G0/G1 accumulation in cell cycle distribution, decreased the transcription and expression of hTERT, and reduced telomerase activity compared with controls in T24 and EJ cells. Mad1 also arrested tumor growth and downregulated hTERT expression and telomerase activity in bladder cancer xenograft BALB/c nude mice.
Conclusions:
Mad1 inhibited the proliferation of human bladder cancer cells by inhibiting hTERT transcription and telomerase activity. Mad1 could be a potentially useful candidate for inhibition of bladder cancer growth.
Insights
Mitosis arrest deficiency 1 (Mad1) inhibits bladder cancer cell proliferation by suppressing human telomerase reverse transcriptase (hTERT) transcription and telomerase activity. Mad1 shows potential for bladder cancer growth inhibition.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- Bladder cancer remains a significant health concern.
- Understanding novel therapeutic targets is crucial for effective treatment.
Purpose of the Study:
- To investigate the effects of Mad1 on bladder cancer cell proliferation.
- To elucidate the underlying mechanisms involving hTERT and telomerase activity.
Main Methods:
- Utilized MTT assay, flow cytometry, and luciferase assays.
- Assessed hTERT expression and telomerase activity via TRAP-ELISA and qRT-PCR.
- Evaluated effects in vitro (T24, EJ cells) and in vivo (xenograft models).
Main Results:
- Mad1 significantly inhibited bladder cancer cell proliferation.
- Mad1 induced G0/G1 cell cycle arrest.
- Mad1 downregulated hTERT transcription, expression, and telomerase activity in cells and tumors.
Conclusions:
- Mad1 inhibits bladder cancer growth by targeting hTERT transcription and telomerase activity.
- Mad1 presents a potential therapeutic candidate for bladder cancer treatment.
More Related Videos
Related Concept Videos
Mitogens and the Cell Cycle
Replicative Cell Senescence
Abnormal Proliferation
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Targeted Cancer Therapies
There are several types of targeted therapies against specific...

